BACKGROUND: Preclinical trials have shown beneficial effects of nerve growth factor (NGF) administration on visual function in animal models of retinitis pigmentosa (RP). The aim of this pilot study was to explore the potential efficacy of short term NGF eye drops treatment in patients affected by RP. METHODS: The trial consisted in 10 days daily administration of murine NGF as eye-drops for a total dose of 1 mg NGF/pt. Eight RP patients at an advanced stage of the disease were included in the trial. To monitor safety and potential adverse effects subjects underwent standard clinical measures and were requested to report any general or topic alterations following NGF assumption. Retinal function was assessed at baseline and after treatment by best-corrected visual acuity measurement (BCVA), macular focal electroretinogram (fERG) recording and Goldmann visual field testing. RESULTS: A transient tolerable local corneal irritation was the only adverse effect reported. fERG and BCVA remained within the limits determined by test-retest analysis of a large cohort of RP patients. Three patients reported a subjective feeling of improved visual performance. This was associated to a temporary enlargement of the visual field in all three patients and to improved fERG in two of the three. CONCLUSIONS: Short-term administration of NGF eye-drops caused neither significant adverse effects nor visual function losses in the tested RP patients. A minority of patients experienced an improvement of visual performance as shown by Goldmann visual field and fERG. This study supports the safety and possible efficacy of NGF eye-drops administration in RP patients. TRIAL REGISTRATION: EudraCT n. 2008-004561-26.

Falsini, B., Iarossi, G., Chiaretti, A., Ruggiero, A., Manni, L., Galli Resta, L., Corbo, G., Abed, E., NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study, <<JOURNAL OF TRANSLATIONAL MEDICINE>>, 2016; 14 (1): N/A-N/A. [doi:10.1186/s12967-015-0750-3] [http://hdl.handle.net/10807/70245]

NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study

Falsini, Benedetto;Iarossi, Giancarlo;Chiaretti, Antonio;Ruggiero, Antonio;Abed, Edoardo
2016

Abstract

BACKGROUND: Preclinical trials have shown beneficial effects of nerve growth factor (NGF) administration on visual function in animal models of retinitis pigmentosa (RP). The aim of this pilot study was to explore the potential efficacy of short term NGF eye drops treatment in patients affected by RP. METHODS: The trial consisted in 10 days daily administration of murine NGF as eye-drops for a total dose of 1 mg NGF/pt. Eight RP patients at an advanced stage of the disease were included in the trial. To monitor safety and potential adverse effects subjects underwent standard clinical measures and were requested to report any general or topic alterations following NGF assumption. Retinal function was assessed at baseline and after treatment by best-corrected visual acuity measurement (BCVA), macular focal electroretinogram (fERG) recording and Goldmann visual field testing. RESULTS: A transient tolerable local corneal irritation was the only adverse effect reported. fERG and BCVA remained within the limits determined by test-retest analysis of a large cohort of RP patients. Three patients reported a subjective feeling of improved visual performance. This was associated to a temporary enlargement of the visual field in all three patients and to improved fERG in two of the three. CONCLUSIONS: Short-term administration of NGF eye-drops caused neither significant adverse effects nor visual function losses in the tested RP patients. A minority of patients experienced an improvement of visual performance as shown by Goldmann visual field and fERG. This study supports the safety and possible efficacy of NGF eye-drops administration in RP patients. TRIAL REGISTRATION: EudraCT n. 2008-004561-26.
Inglese
Falsini, B., Iarossi, G., Chiaretti, A., Ruggiero, A., Manni, L., Galli Resta, L., Corbo, G., Abed, E., NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study, <>, 2016; 14 (1): N/A-N/A. [doi:10.1186/s12967-015-0750-3] [http://hdl.handle.net/10807/70245]
File in questo prodotto:
File Dimensione Formato  
70245OA.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 974.94 kB
Formato Adobe PDF
974.94 kB Adobe PDF Visualizza/Apri
NGF eye-drops in retinitis pigmentosa.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 974.94 kB
Formato Unknown
974.94 kB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/70245
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 29
social impact